Skip to main content
All lobbying filings

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.)

McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.) filed a Q1 report for McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions on April 21, 2025.

Lobbying for McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions

As filed: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS.

All filings by McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions (Formerly McKesson Corp.) · Everything McKesson Corporation & Affiliates U.S. Oncology and RX Savings Solutions has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Apr 24, 2025.
 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$1,220,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Texas

Official filing document

 Lobbyists on this filing 1
  • BRIAN BRANTON New on this filing
    Previously held: Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5
Health Issues

Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response. PAHPA Reauthorization; Healthcare innovation, ARPA-H, oncology research; Community Health Center Reauthorization; Benefit cost and transparency, real time benefit tools and patient APIs - S. 1339; Controlled Substance Reporting; Pharmaceutical Manufacturing and Supply Chain Shortage; Alleviating Drug Shortages; Telehealth Modernization Act of 2024; H.R.4011 Timely Access to Cancer Treatment Act; H.R.2630, S.652 The Safe Step Act; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act; H.R. 4473, Medicare Patient Access to Cancer Treatment Act; HR 2484 Seniors Access to Critical Medications Act.

Medicare/Medicaid

Equitable Community Access to Pharmacist Services Act; Healthcare innovation and oncology research; H.R.3173, S.3018 The Improving Seniors Timely Access to Care Act; Medically integrated physician dispensing regulations; HR 2484 Seniors Access to Critical Medications Act

Pharmacy

Equitable Community Access to Pharmacist Services Act; H.R. 4011 Timely Access to Cancer Treatment; Medically integrated physician dispensing regulations; S.127, PBM Transparency Act; Drug price transparency and cost savings opportunities.

Taxation/Internal Revenue Code

Last-in, first-out (LIFO) Inventory Accounting Method; H.R.5376 The Inflation Reduction Act

Tariff (miscellaneous tariff bills)

H.R.5376 The Inflation Reduction Act

 Bills named in this filing 12
  • S. 1339
    Pharmacy Benefit Manager Reform Act
  • H.R. 4011
    Community Paramedicine Act of 2025
  • H.R. 2630
    Safe Step Act
  • S. 652
    Protecting Patients from Deceptive Drug Ads Act
  • H.R. 2474
    Strengthening Medicare for Patients and Providers Act
  • H.R. 3561
    PATIENT Act of 2023
  • H.R. 4473
    Medicare Patient Access to Cancer Treatment Act
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
  • H.R. 3173
    Improving Seniors’ Timely Access to Care Act of 2022
  • S. 3018
    Improving Seniors’ Timely Access to Care Act of 2021
  • S. 127
    Pharmacy Benefit Manager Transparency Act of 2023
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem